- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
27
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
27 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
2111 | HK$2.21 | -0.5% | 114.6% | HK$2.3b | HK$1.93 | PE6.6x | E24.3% | 7.5% | Consumer Durables | ||
1119 | HK$2.21 | 0% | -25.1% | HK$3.8b | HK$4.84 | PS1.8x | E104.1% | n/a | Media | ||
1382 | HK$1.53 | -3.2% | -12.6% | HK$2.1b | HK$3.32 | PE12.8x | E37.7% | 7.8% | Consumer Durables | ||
285 | HK$29.95 | 2.7% | -7.3% | HK$66.9b | HK$43.37 | PE15.3x | E22.3% | 2.0% | Tech | ||
3738 | HK$1.51 | 22.8% | -42.1% | HK$3.2b | HK$6.49 | PS1.7x | E66.6% | n/a | Software | ||
2013 | HK$1.31 | 10.1% | -66.2% | HK$4.1b | HK$2.27 | PS1.7x | E109.7% | n/a | Software | ||
799 | HK$2.47 | -3.9% | -28.2% | HK$2.9b | HK$4.22 | PE38.3x | E51.2% | n/a | Media | ||
596 | HK$3.34 | -4.8% | 34.7% | HK$3.8b | HK$5.00 | PE17.3x | E38.0% | 0.9% | Software | ||
1911 | HK$7.27 | 0% | -26.2% | HK$4.1b | HK$12.69 | PS2.6x | E97.8% | 5.7% | Diversified Financials | ||
3998 | HK$4.03 | 3.9% | 30.8% | HK$43.4b | HK$5.58 | PE13.1x | E12.4% | 6.2% | Consumer Durables | ||
3393 | HK$6.54 | 2.2% | 124.0% | HK$6.6b | HK$6.93 | PE11.4x | E25.8% | 4.3% | Tech | ||
2325 | HK$8.00 | -3.6% | -33.0% | HK$5.0b | HK$13.99 | PS4.9x | E97.8% | 0.2% | Healthcare | ||
2400 | HK$20.85 | 2.7% | 28.5% | HK$9.9b | HK$22.20 | PS2.7x | E53.7% | n/a | Media | ||
6616 | HK$3.86 | 4.3% | -9.2% | HK$4.8b | HK$5.83 | PE24.1x | E22.3% | 0% | Materials | ||
1801 | HK$43.45 | 5.8% | 41.3% | HK$67.5b | HK$56.77 | PS10.4x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
1548 | HK$12.24 | -4.4% | -31.9% | HK$26.7b | HK$23.93 | PS3.3x | E113.4% | 0% | Pharmaceuticals & Biotech | ||
9923 | HK$10.72 | 0.4% | -34.3% | HK$4.6b | HK$15.75 | PE361.5x | E34.0% | n/a | Diversified Financials | ||
669 | HK$104.00 | 6.6% | 31.5% | HK$189.3b | HK$117.45 | PE23.3x | E15.3% | 2.1% | Capital Goods | ||
867 | HK$7.07 | 6.8% | -36.2% | HK$17.3b | HK$10.74 | PE11.4x | E21.9% | 6.1% | Pharmaceuticals & Biotech | ||
1952 | HK$18.50 | -3.0% | 3.5% | HK$6.1b | HK$26.07 | PS43.1x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
1972 | HK$14.18 | 0% | -15.3% | HK$83.9b | HK$17.94 | PE37.5x | E25.3% | 7.5% | Real Estate Management and Development | ||
1516 | HK$1.71 | -1.2% | -21.6% | HK$5.2b | HK$1.87 | PB0.8x | E60.4% | 9.1% | Real Estate Management and Development | ||
9699 | HK$10.88 | 7.7% | 31.2% | HK$15.8b | HK$13.14 | PE228.1x | E50.4% | n/a | Transportation | ||
1821 | HK$11.46 | 0.9% | -2.4% | HK$49.0b | HK$15.40 | PE30.7x | E26.3% | 2.2% | Real Estate Management and Development |